EnteraGam® IBS-D Clinical Study Results
- EnteraGam® significantly reduced the number of days patients experienced loose stools and other IBS-D symptoms1
- Frequency of loose stools was reduced from 5 days a week to 3 days a week (average)1
Decrease in Mean Number of Days With Global IBS-D Symptoms1,*
|Some people notice management of their condition with EnteraGam® in as little as 2 to 4 weeks2|
*Results from a 6-week, randomized, double-blind, placebo-controlled study (N = 66). Subjects received either EnteraGam® 10 g daily (n = 25), 5 g daily (n = 19), or placebo (n = 22). Subjects self-assessed presence and severity of GI symptoms daily using a 4-point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). Number of days with symptoms was calculated for each 2-week period per subject. Data above represent within-group changes from baseline to end of study among the 15 subjects taking 10 g of EnteraGam® daily (recommended dose is 5 g to 20 g daily). Within the placebo group (soy protein), there was no statistically significant reduction in the number of days with any GI-related symptoms. Study was not powered to demonstrate between-group differences. The findings from this study suggest that EnteraGam® provides for a distinctive nutritional requirement unique for IBS-D patients which could not be provided for by soy protein.